Category & Conditions: Cancer
Study Phase : 3
Medicine: BOSULIF®(BOSUTINIB)
PrintDownloadCategory & Conditions: Cancer
Study Phase : 1
Medicine: DAURISMO TABLETS(GLASDEGIB)
PrintDownloadCategory & Conditions: Cancer
Study Phase : 3
Medicine: TRAZIMERA FOR INJECTION(TRASTUZUMAB-QYYP)
PrintDownloadCategory & Conditions: Neurological Diseases and Conditions
Study Phase : 3
Medicine: VYNDAQEL® (TAFAMIDIS MEGLUMINE) CAPSULES AND VYNDAMAX™ (TAFAMIDIS) CAPSULES
PrintDownloadCategory & Conditions: Cancer
Study Phase : 3
Medicine: XALKORI®(CRIZOTINIB)
PrintDownloadCategory & Conditions: Cancer
Study Phase : 2
Medicine: XALKORI®(CRIZOTINIB)
PrintDownloadCategory & Conditions: Cancer
Study Phase : 1
Medicine: XALKORI®(CRIZOTINIB)
PrintDownloadCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 4
Medicine: XELJANZ®(TOFACITINIB)
PrintDownloadCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 4
Medicine: XELJANZ®(TOFACITINIB)
PrintDownloadCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 3
Medicine: XELJANZ®(TOFACITINIB)
PrintDownloadCategory & Conditions: Skin Diseases and Conditions
Study Phase : 3
Medicine: abrocitinib (PF-04965842)
PrintDownloadCategory & Conditions: Skin Diseases and Conditions
Study Phase : 3
Medicine: abrocitinib (PF-04965842)
PrintDownloadCategory & Conditions: Skin Diseases and Conditions
Study Phase : 2
Medicine: brepocitinib (PF-06700841)
PrintDownloadCategory & Conditions: Skin Diseases and Conditions
Study Phase : 3/4
Medicine: Eucrisa (crisaborole)
PrintDownloadCategory & Conditions: Rare Diseases
Study Phase : 2
Medicine: marstacimab (PF-06741086)
PrintDownloadCategory & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PF-06482077
PrintDownloadCategory & Conditions: Vaccine-related Conditions
Study Phase : 2
Medicine: PF-06760805
PrintDownloadCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 2
Medicine: PF-06826647
PrintDownloadCategory & Conditions: Vaccine-related Conditions
Study Phase : 2
Medicine: PF-06842433
PrintDownloadCategory & Conditions: Vaccine-related Conditions
Study Phase : 1/2
Medicine: PF-06928316
PrintDownload